SRx Health Solutions receives NYSE American warning letter over 7.5M share issuance without approval

SRx Health Solutions, Inc.

NYSE American issued public warning letter on Feb 18, 2026 citing violations of Sections 301 and 713.
Company failed to file listing application and obtain shareholder approval for issuance of approx. 7.5 million shares upon conversion of Series A Preferred Stock.
Company had obtained stockholder approval by written consent on Oct 8, 2025, but NYSE deemed it deficient under internal guidance.
All preferred shares have been converted or redeemed as of report date; no preferred shares outstanding.
Company filed Form 8-K and press release on Feb 20, 2026 disclosing the warning letter.

item 3.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.